Skip to main content
Top

Open Access 05-06-2025 | Primary Sjögren Syndrome | ORIGINAL ARTICLE

Artificial intelligence-based prediction of organ involvement in Sjogren’s syndrome using labial gland biopsy whole-slide images

Authors: Yong Ren, Wenqi Xia, Jiayun Wu, Zheng Yang, Ye Jiang, Ya Wen, Qiuquan Guo, Jieruo Gu, Jun Yang, Jun Luo, Qing Lv

Published in: Clinical Rheumatology

Login to get access

Abstract

Objectives

This study aimed to develop a deep learning-based model to predict the risk of high-risk extra-glandular organ involvement (HR-OI) in patients with Sjogren’s syndrome (SS) using whole-slide images (WSI) from labial gland biopsies.

Methods

We collected WSI data from 221 SS patients. Pre-trained models, including ResNet50, InceptionV3, and EfficientNet-B5, were employed to extract image features. A classification model was constructed using multi-instance learning and ensemble learning techniques.

Results

The ensemble model achieved high area under the receiver operating characteristic (ROC) curve values on both internal and external validation sets, indicating strong predictive performance. Moreover, the model was able to identify key pathological features associated with the risk of HR-OI.

Conclusions

This study demonstrates that a deep learning-based model can effectively predict the risk of HR-OI in SS patients, providing a novel basis for clinical decision-making.
Key Points
1. What is already known on this topic?
Sjogren’s syndrome (SS) is a chronic autoimmune disease affecting the salivary and lacrimal glands.
Accurate prediction of high-risk extra-glandular organ involvement (HR-OI) is crucial for timely intervention and improved patient outcomes in SS.
Traditional methods for HR-OI prediction rely on clinical data and lack objectivity.
2. What this study adds?
This study proposes a novel deep learning-based model using whole-slide images (WSI) from labial gland biopsies for predicting HR-OI in SS patients.
Our model utilizes pre-trained convolutional neural networks (CNNs) and a Vision Transformer (ViT) module to extract informative features from WSI data.
The ensemble model achieves high accuracy in predicting HR-OI, outperforming traditional methods.
The model can identify key pathological features in WSI data associated with HR-OI risk.
3. How this study might affect research, practice or policy?
This study provides a novel and objective approach for predicting HR-OI in SS patients, potentially leading to improved clinical decision-making and personalized treatment strategies.
Our findings encourage further investigation into the role of deep learning and WSI analysis in SS diagnosis and risk stratification.
The development of a non-invasive and objective diagnostic tool based on WSI analysis could benefit clinical practice and inform policy decisions regarding patient care for SS.The development of a non-invasive and objective diagnostic tool based on WSI analysis could benefit clinical practice and inform policy decisions regarding patient care for SS.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Artificial intelligence-based prediction of organ involvement in Sjogren’s syndrome using labial gland biopsy whole-slide images
Authors
Yong Ren
Wenqi Xia
Jiayun Wu
Zheng Yang
Ye Jiang
Ya Wen
Qiuquan Guo
Jieruo Gu
Jun Yang
Jun Luo
Qing Lv
Publication date
05-06-2025
Publisher
Springer International Publishing
Published in
Clinical Rheumatology
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-025-07518-5

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more